Detalhe da pesquisa
1.
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.
N Engl J Med
; 382(2): 140-151, 2020 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31914241
2.
p65/RelA NF-κB fragments generated by RIPK3 activity regulate tumorigenicity, cell metabolism, and stemness characteristics.
J Cell Biochem
; 123(3): 543-556, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34927768
3.
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.
Br J Haematol
; 198(3): 535-544, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35438802
4.
Single-agent 5-azacytidine as post-transplant maintenance in high-risk myeloid malignancies undergoing allogeneic hematopoietic cell transplantation.
Ann Hematol
; 101(6): 1321-1331, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35352216
5.
Involvement of ORAI1/SOCE in Human AML Cell Lines and Primary Cells According to ABCB1 Activity, LSC Compartment and Potential Resistance to Ara-C Exposure.
Int J Mol Sci
; 23(10)2022 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35628366
6.
Small myeloid subclones are present at diagnosis of multiple myeloma in patients who develop secondary myelodysplastic syndromes.
Haematologica
; 109(4): 1289-1292, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855058
7.
Successful bridging to cell therapy for relapsed/refractory acute lymphoblastic leukaemia with a combination of venetoclax and PEG-asparaginase.
Br J Haematol
; 200(4): e37-e39, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36470305
8.
Isolation and characterization of two canine melanoma cell lines: new models for comparative oncology.
BMC Cancer
; 18(1): 1219, 2018 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514258
9.
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia.
Blood
; 125(23): 3618-26, 2015 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25852055
10.
Monocyte chemoattractant protein 1 (MCP-1/CCL2) contributes to thymus atrophy in acute myeloid leukemia.
Eur J Immunol
; 45(2): 396-406, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25382729
11.
GILZ overexpression attenuates endoplasmic reticulum stress-mediated cell death via the activation of mitochondrial oxidative phosphorylation.
Biochem Biophys Res Commun
; 478(2): 513-20, 2016 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27416758
12.
Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia.
Blood
; 134(26): 2414-2416, 2019 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31697825
13.
MYD88 L265P mutation in Waldenstrom macroglobulinemia.
Blood
; 121(22): 4504-11, 2013 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23532735
14.
MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome.
Br J Haematol
; 167(4): 506-13, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25160558
15.
Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML.
Blood
; 130(6): 832-835, 2017 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28611023
16.
The PI3K/AKT signaling pathway controls the quiescence of the low-Rhodamine123-retention cell compartment enriched for melanoma stem cell activity.
Stem Cells
; 31(4): 641-51, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23355370
17.
Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study.
Eur J Haematol
; 93(5): 429-38, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24813620
18.
Comprehensive molecular landscape in patients older than 80 years old diagnosed with acute myeloid leukemia: A study of the French Hauts-de-France AML observatory.
Am J Hematol
; 94(1): E24-E27, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30358899
19.
Azacitidine in untreated acute myeloid leukemia: a report on 149 patients.
Am J Hematol
; 89(4): 410-6, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24375487
20.
Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9-dependent AML.
Hemasphere
; 8(5): e77, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38716146